Fig. 1 (abstract P192).From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part twoArithmetic mean (SE) predose serum concentration-time profile of pembrolizumab following multiple doses of pembrolizumab plus ipilimumab (linear-linear scale)Back to article page